- Media & Publications
It is with deep concern that ECPI notes the ECHA Member State Committee has concluded that DEHP is an endocrine disruptor of equivalent level of concern for its environmental properties. The science on DEHP does not support such a conclusion as the weight of evidence shows that DEHP does not cause adverse endocrine effects in fish and other aquatic organisms. This was also the reason for non-classification for environmental hazards in the conclusion of the EU DEHP RAR (Risk Assessment Report) which at the time had been agreed by all member states. In addition, lack of reproductive effects in primates and species differences for rat, mouse and humans is not in agreement with a concern for mammals in the environment. Moreover, DEHP does not bio accumulate and therefore DEHP cannot pose a hazard to higher mammals in the environment. ECPI does not agree with the Member State Committee that the WHO/IPCS definition of adverse effects consequent to an endocrine mode of action, for the environment, has been met and demonstrated in the dossiers submitted. “We can only conclude that the decision has been political rather than science based” stated Dr. Stephane Content of ECPI.
Brussels, 10 December 2014: Representatives from the entire flexible PVC value chain met this week at the Plasticisers Conference 2014 to discuss the latest developments in the sector.Participants agreed on the need for improved coordination amongst EU and national regulators to guarantee a competitive and cost effective level playing field for the entire chemical industry.
Prague, 26 November 2014 – The European Council for Plasticisers and Intermediates (ECPI) recently held a flexible PVC and plasticisers workshop with representatives from Czech regulatory bodies and leading companies making flexible PVC products. They discussed the role and contribution of the plasticisers industry to the EU economy, recent policy and regulatory developments, and the most important regulatory challenges lying ahead, both at European and national level.
The European Council for Plasticisers and Intermediates (ECPI) is committed to the safety and sustainability of plasticisers, human health being of paramount importance for the European plasticisers producers. For this reason, ECPI experts wish to address the misconceptions related to the conclusions of a study presented in the recent publication by Bornehag (2014)[i] on pre-natal phthalate exposure and anogenital distance in Swedish boys and broadly alarmingly reported by several European media.
On 21 October 2014, Dr. Emily Barrett, of the University of Rochester School of Medicine in New York State, presented a study under a speculative and unjustified title claiming that “environmental phthalate exposure is associated with low interest in sexual activity in premenopausal women”. The study, for which only a short abstract has so far been published, aimed at establishing a potential link between sexual health self-assessment reports collected from 360 American women and the presence of urinary metabolites of DEHP.